Session Details

U072 Social Media and Ethics: A Point-Counterpoint Debate

Sun, Mar 9, 8:00 AM - 9:00 AM
W414B
1 CME Available Focus Session NEW
View Map

DESCRIPTION

Open admission to eligible categories, no tuition or ticket

Should dermatologists promote sponsored products on professional media pages? Should skincare product companies sponsor non-professional "influencers" to promote their products? This interactive, case-based, debate-style session will review foundational and contemporary ethical controversies in dermatology using a point-counterpoint format, with a special emphasis on social media in dermatology. Attendees will learn practical approaches to addressing ethically challenging scenarios in dermatology.

LEARNING OBJECTIVES

1.

Identify ethical dilemmas that practicing dermatologists in 2025 encounter on a regular basis with an emphasis on social media.

2.

Using ethical frameworks, outline arguments for and against the ways to address these dilemmas.

3.

Demonstrate techniques by which dermatologists can navigate ethical dilemmas in their daily practice.

SCHEDULE

12:00 PM

Use of Non-Professional Influencers by Dermatology Skincare Companies

Stephanie Fabbro, MD, FAAD, William Huang, MD, MPH, FAAD

12:20 PM

Confidentiality and Patient Privacy in Dermatologic Social Media Content

Cheryl M. Burgess, MD, FAAD, Stephanie Mengden, MD, FAAD

12:40 PM

Separating personal and professional advocacy on political issues in social media

Anne Louise Housholder, MD, FAAD, Jules Lipoff, MD, FAAD

SPEAKERS

Cheryl M. Burgess, MD, FAAD

Cheryl M. Burgess, MD, FAAD

Stephanie Fabbro, MD, FAAD

Stephanie Fabbro, MD, FAAD

Anne Louise Housholder, MD, FAAD

Anne Louise Housholder, MD, FAAD

William Huang, MD, MPH, FAAD

William Huang, MD, MPH, FAAD

Jules Lipoff, MD, FAAD

Jules Lipoff, MD, FAAD

Stephanie Mengden, MD, FAAD

Stephanie Mengden, MD, FAAD

SPEAKER DISCLOSURES

Cheryl M. Burgess, MD, FAAD

Aerolase – Investigator(Equipment); Allergan, Inc. – Investigator(Grants/Research Funding), Stockholder(Stock); Janssen Pharmaceuticals, Inc – Investigator(Grants/Research Funding); Merz Aesthetics – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Pfizer Inc. – Investigator(Grants/Research Funding); Prollenium – Investigator(Grants/Research Funding); Revance Therapeutics, Inc. – Investigator(Grants/Research Funding); Target Cool – Advisory Board(Equipment); TEOXANE Laboratories – Investigator(Grants/Research Funding);

Stephanie Fabbro, MD, FAAD

Beiersdorf – Speaker(Honoraria); Bristol-Myers Squibb – Advisory Board(Honoraria); Castle Biosciences, Inc – Investigator(Grants/Research Funding); Kyowa Kirin – Speaker(Honoraria);

Anne Louise Housholder, MD, FAAD

PatientPoint – Consultant(Honoraria);

William Huang, MD, MPH, FAAD

Dermatology Foundation – Other(No Compensation Received); Medical Dermatology Society – Board of Directors(No Compensation Received);

Jules Lipoff, MD, FAAD

AlphaSights – Consultant (1099 relationship)(Fees); Amgen – Consultant (1099 relationship)(Fees); Boehringer Ingelheim – Consultant (1099 relationship)(Honoraria); Guidepoint Global, LLC – Consultant(Fees); RBC Consultants – Consultant (1099 relationship)(Honoraria); Springer Science & Business Media – Other(Patent royalties or other compensation for Intellectual Property Rights); UpToDate – Other(Other Financial Benefit);

Stephanie Mengden, MD, FAAD

No financial relationships exist with ineligible companies.